SS
Sunil Shukla
About Sunil Shukla
Data last updated:
Sunil Shukla is a Director at Nektap Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Nektap Pharmaceuticals Private Limited reported revenue of ₹2.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2021 | 2017 | ₹2.5 Lakh (FY 2024) | Active |
Board colleagues of Sunil Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aliya Rizvi | 06876379 | Nektap Pharmaceuticals Private Limited | Director |
| Monika Saini | 09675988 | Nektap Pharmaceuticals Private Limited | Director |
| Vishal Sahai | 07952273 | Nektap Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Shukla
Sunil Shukla currently holds 1 directorship: Nektap Pharmaceuticals Private Limited (Director, since 01 Sep 2021, revenue ₹2.5 Lakh (FY 2024)).
Sunil Shukla was first appointed on 01 Sep 2021 as Director at Nektap Pharmaceuticals Private Limited.
The current boards of Sunil Shukla's companies include Aliya Rizvi (Nektap Pharmaceuticals Private Limited), Monika Saini (Nektap Pharmaceuticals Private Limited), Vishal Sahai (Nektap Pharmaceuticals Private Limited).